Intuitive Surgical, Inc.
ISRG Healthcare Medical Instruments & Supplies
Intuitive Surgical, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $10.1 billion, up 20.5% from fiscal 2024. In the quarter to June 2026, revenue grew 18.5%, EPS grew 25.5% and free cash flow grew 69.3%, each against the same quarter a year earlier. Member of the S&P 500 and Nasdaq 100; revenue growth for five consecutive years, operating cash flow growth for three.
Follow ISRG
Intuitive Surgical, Inc. (ISRG) Shares outstanding
Intuitive Surgical, Inc.'s shares outstanding at the end of fiscal 2025 was $362.7M, unchanged from fiscal 2024. At the end of the quarter to 30 June 2026 it was $357.3M. Over the past ten years it has ranged from $341.1M (fiscal 2015) to $365.8M (fiscal 2021); the current reading is higher than 91% of that period. Intuitive Surgical, Inc. ranks 5th of 50 Medical Instruments & Supplies companies by shares outstanding.
Shares outstanding, annual
Embed this chart
Annual newest first
| Period | Shares outstanding | Change |
|---|---|---|
| FY2025 | $362.7M | 0.19% |
| FY2024 | $362.0M | 1.29% |
| FY2023 | $357.4M | (1.27%) |
| FY2022 | $362.0M | (1.04%) |
| FY2021 | $365.8M | 1.33% |
| FY2020 | $361.0M | 0.73% |
| FY2019 | $358.4M | 0.56% |
| FY2018 | $356.4M | 2.15% |
| FY2017 | $348.9M | (1.36%) |
| FY2016 | $353.7M | 3.69% |
Quarterly newest first
| Period | Shares outstanding | Change |
|---|---|---|
| Jun 2026 | $357.3M | (0.69%) |
| Mar 2026 | $359.8M | (0.80%) |
| Dec 2025 | $362.7M | 0.25% |
| Sep 2025 | $361.8M | (0.63%) |
| 42 more quarters | Free account |
Against its own ten years
Shares outstanding against peers
| Company | Shares outstanding |
|---|---|
| MDLN Medline Inc. compare | $861.0M |
| BAX Baxter International Inc. compare | $518.0M |
| ALC Alcon compare | $488.7M |
| ISRG Intuitive Surgical, Inc. | $357.3M |
| BDX Becton, Dickinson and Company compare | $275.2M |
| SOLV Solventum Corporation compare | $173.3M |
| RMD ResMed Inc. compare | $146.1M |
| WST West Pharmaceutical Services, Inc. compare | $71.3M |
| RGEN Repligen Corporation compare | $56.6M |
What Shares outstanding is
Shares (Diluted, Weighted) tells an investor how many shares a company’s earnings are spread across once potential new shares are counted.
Reported line item
More on ISRG
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement